HMOX1 and hepatocellular carcinoma: In the context of HCC, aberrant activation of antioxidant pathways such as the Nrf2-HO-1 axis, along with upregulation of ferroptosis-suppressing proteins like GPX4 and FTH1, confers resistance to oxidative stress and chemotherapy-induced cell death 35.